41 articles
Jeremy Levin, Chairman and CEO of Ovid Therapeutics, Inc., and former chairman of the global Biotechnology Innovation Organization (BIO) discusses the n...
Dave Ross, VP of Commercial Operations - North America at Seqirus discusses the recent FDA approval of FLUCELVAX® QUADRIVALENT, Seqirus’ cell-based q...
Patricia Whitley-Williams, President of the National Foundation for Infectious Diseases (NFID) discusses the persistent gaps and racial disparities in v...
Michelle Goveia, MD, Executive Director, Global Medical and Scientific Affairs at Merck Vaccines and Dr. Learn more on Health Professional Radio.
Joseph Hernandez, Founder and CEO of Blue Water Vaccines discusses the company's development of a universal influenza vaccine. Current research and de...
Len Friedland, VP and Director, Scientific Affairs and Public Health Vaccines at GSK discusses the increase in vaccine preventable hepatitis A cases in ...
Maria Milla, MD, Section Chief, Nicklaus Children's Pediatric Care Centers discusses the importance of flu vaccinations for children and their parents e...
Gregg Sylvester, Chief Medical Officer at Seqirus discusses real-world evidence on the company’s MF59® Adjuvanted, Trivalent Influenza Vaccine that...
Gregg Sylvester, Chief Medical Officer at Seqirus discusses real-world evidence on the company’s cell-based quadrivalent influenza vaccine (QIVc), whi...
Maria Milla, M.D., Section Chief, Nicklaus Children's Pediatric Care Centers discusses pediatric immunizations and the recommendation to not delay wheth...